Beth A Reboussin Selected Research

N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 2- yl)benzamide

5/2007

Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beth A Reboussin Research Topics

Disease

8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 09/2018
5	Marijuana Use 09/2015 - 01/2010
4	Cocaine-Related Disorders (Cocaine Addiction) 09/2012 - 09/2006
3	Type 2 Diabetes Mellitus (MODY) 11/2022 - 01/2019
3	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 10/2020
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017 - 05/2016
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2022 - 01/2019
2	Substance-Related Disorders (Drug Abuse) 01/2010 - 09/2006
2	Breast Neoplasms (Breast Cancer) 11/2005 - 07/2004
1	Hypoglycemia (Reactive Hypoglycemia) 11/2022
1	Genetic Risk Score 01/2022
1	Obesity 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Albuminuria 01/2020
1	Diabetes Complications 01/2020
1	Overweight 01/2020
1	Binge Drinking 01/2020
1	Insulin Resistance 01/2019
1	Sneezing 10/2006
1	Inflammation (Inflammations) 04/2006
1	Tobacco Use Disorder (Nicotine Dependence) 07/2004
1	Infections 06/2004
1	Rheumatoid Arthritis 06/2004
1	Sinusitis 06/2004
1	Mood Disorders (Mood Disorder) 07/2003

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 09/2015 - 04/2007
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2021
2	Insulin (Novolin)FDA Link 01/2022 - 01/2019
2	Heroin (Diamorphine)IBA 01/2021 - 10/2020
2	LipidsIBA 01/2020 - 01/2020
2	Hormones (Hormone)IBA 04/2006 - 11/2005
2	Estrogens (Estrogen)FDA Link 04/2006 - 07/2004
2	Progestins (Progestagens)IBA 04/2006 - 07/2004
1	Narcotics (Narcotic Analgesics)IBA 10/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 09/2018
1	Dopamine (Intropin)FDA LinkGeneric 09/2012
1	Illicit Drugs (Recreational Drugs)IBA 05/2011
1	benzamideIBA 05/2007
1	fluoreneIBA 05/2007
1	Dopamine D3 ReceptorsIBA 05/2007
1	NGB 2904IBA 05/2007
1	N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 2- yl)benzamideIBA 05/2007
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2006
1	Cocaine (Cocaine HCl)IBA 09/2006
1	SolutionsIBA 09/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2006
1	Matrix Metalloproteinases (MMPs)IBA 04/2006
1	SteroidsIBA 11/2005
1	SmokeIBA 07/2004
1	CoagulaseIBA 06/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2004
1	AllergensIBA 06/2004

Therapy/Procedure

8	Glycemic Control 11/2022 - 09/2018
4	Therapeutics 01/2019 - 06/2004
3	Condoms (Condom) 01/2017 - 05/2016
1	Injections 01/2022
1	Patient Readmission 07/2003